NASDAQ:MAZE | Cash Flow Statement | Maze Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2024-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$44.73M
2026-03-31-$24.21M-$39.11M$93,000.00$6.28M$42.36M
2025-12-31-$34.57M-$27.73M$34,000.00-$103.39M$3.59M
2025-09-30-$30.09M
2025-06-30-$33.68M
2025-03-31-$32.79M-$29.52M$299,000.00-$299,000.00$127.38M
2024-12-31-$29.58M-$22.45M$605,000.00-$605,000.00$70.26M
2024-09-30-$24.75M
2024-06-30$139.06M
2024-03-31-$32.49M-$23.44M$279,000.00-$279,000.00$24.58M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$131.12M-$111.94M$794,000.00-$170.96M$275.34M
2024-12-31$52.23M$75.95M$1.15M-$1.15M$92.85M